X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

“Stand-Alone” HRAs Are Back – Sort Of: Individual Coverage HRAs May Offer Simpler Means For Compliance With Employer Mandate

The U.S. agencies in charge of issuing guidance under the Patient Protection and Affordable Care Act...

Read More >

BREAKING NEWS: Illinois Recreational Cannabis Law Protections For Employers & The Workplace Clarified!

As Illinois set out to become the first state to legalize recreational cannabis through statutory au...

Read More >

Covid–19 coronavirus update: global application of foreign investment control rules

The table below sets out an overview, based on our current awareness of the position as regards fore...

Read More >

New Jersey Offers More Workplace Protections for Medical Cannabis Patients

A combination of New Jersey court decisions and legislative actions have expanded and clarified New ...

Read More >

NLRB Rejects Clause Mandating Arbitration Of All Disputes

The National Labor Relations Board recently invalidated an arbitration agreement that would require ...

Read More >

A Challenge Regarding the Interpretation of a Project Condition of Approval may be Filed More than 90 Days Following the Project Approval

On June 25, 2020, the Fifth Appellate District decided Honchariw v. County of Stanislaus, holding th...

Read More >